Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients

NCT04401293 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

257

Enrollment

OTHER

Sponsor class

Conditions

Sars-CoV2
COVID

Interventions

DRUG: Enoxaparin
DRUG: Prophylactic/Intermediate Dose Enoxaparin

Sponsor

Northwell Health